The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells (ACTG) A5321 Team

被引:8
作者
Copertino, Dennis C., Jr. [1 ]
Holmberg, Carissa S. [2 ]
Weiler, Jared [1 ]
Ward, Adam R. [1 ,2 ]
Howard, J. Natalie [2 ]
Levinger, Callie [2 ]
Pang, Alina P. S. [1 ]
Corley, Michael J. [1 ]
Duendar, Friederike [3 ,4 ,5 ]
Zumbo, Paul [3 ]
Betel, Doron [1 ,3 ,6 ]
Gandhi, Rajesh T. [7 ]
McMahon, Deborah K. [8 ]
Bosch, Ronald J. [9 ]
Linden, Noemi [1 ]
Macatangay, Bernard J. [8 ]
Cyktor, Joshua C. [8 ]
Eron, Joseph J. [10 ]
Mellors, John W. [8 ]
Kovacs, Colin [11 ]
Benko, Erika [11 ]
Bosque, Alberto [2 ]
Jones, R. Brad [1 ]
机构
[1] Weill Cornell Med, Infect Dis Div, Dept Med, New York, NY USA
[2] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA
[3] Weill Cornell Med, Appl Bioinformat Core, New York, NY USA
[4] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA
[5] Catenion GmbH, Berlin, Germany
[6] Weill Cornell Med, Inst Computat Biomed, New York, NY USA
[7] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[8] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA
[9] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA
[10] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA
[11] Maple Leaf Med Clin, Toronto, ON, Canada
关键词
EXPRESSION; RESERVOIR; VIREMIA; REPLICATION; ELIMINATION; LYMPHOCYTES; INFECTION; PERFORIN; PACKAGE; PD-1;
D O I
10.1172/jci.insight.169028
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IL-15 is under clinical investigation toward the goal of curing HIV infection because of its abilities to reverse HIV latency and enhance immune effector function. However, increased potency through combination with other agents may be needed. 3-Hydroxy-1,2,3-benzotriazin-4(3H)-one (HODHBt) enhances IL-15-mediated latency reversal and NK cell function by increasing STAT5 activation. We hypothesized that HODHBt would also synergize with IL-15, via STAT5, to directly enhance HIV -specific cytotoxic T cell responses. We showed that ex vivo IL-15 + HODHBt treatment markedly enhanced HIV-specific granzyme B-releasing T cell responses in PBMCs from antiretroviral therapy- suppressed (ART-suppressed) donors. We also observed upregulation of antigen processing and presentation in CD4+ T cells and increased surface MHC-I. In ex vivo PBMCs, IL-15 + HODHBt was sufficient to reduce intact proviruses in 1 of 3 ART-suppressed donors. Our findings reveal the potential for second-generation IL-15 studies incorporating HODHBt-like therapeutics. Iterative studies layering on additional latency reversal or other agents are needed to achieve consistent ex vivo reservoir reductions.
引用
收藏
页数:16
相关论文
共 72 条
[1]   Fully Differentiated HIV-1 Specific CD8+T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection [J].
Addo, Marylyn M. ;
Draenert, Rika ;
Rathod, Almas ;
Verrill, Cori L. ;
Davis, Benjamin T. ;
Gandhi, Rajesh T. ;
Robbins, Gregory K. ;
Basgoz, Nesli O. ;
Stone, David R. ;
Cohen, Daniel E. ;
Johnston, Mary N. ;
Flynn, Theresa ;
Wurcel, Alysse G. ;
Rosenberg, Eric S. ;
Altfeld, Marcus ;
Walker, Bruce D. .
PLOS ONE, 2007, 2 (03)
[2]  
Amezquita Robert A, 2020, Nat Methods, V17, P242, DOI 10.1038/s41592-019-0700-8
[3]   Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage [J].
Aran, Dvir ;
Looney, Agnieszka P. ;
Liu, Leqian ;
Wu, Esther ;
Fong, Valerie ;
Hsu, Austin ;
Chak, Suzanna ;
Naikawadi, Ram P. ;
Wolters, Paul J. ;
Abate, Adam R. ;
Butte, Atul J. ;
Bhattacharya, Mallar .
NATURE IMMUNOLOGY, 2019, 20 (02) :163-+
[4]   Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer [J].
Bentires-Alj, Mohamed ;
Neel, Benjamin G. .
CANCER RESEARCH, 2007, 67 (06) :2420-2424
[5]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[6]   Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation [J].
Bosque, Alberto ;
Nilson, Kyle A. ;
Macedo, Amanda B. ;
Spivak, Adam M. ;
Archin, Nancie M. ;
Van Wagoner, Ryan M. ;
Martins, Laura J. ;
Novis, Camille L. ;
Szaniawski, Matthew A. ;
Ireland, Chris M. ;
Margolis, David M. ;
Price, David H. ;
Planelles, Vicente .
CELL REPORTS, 2017, 18 (05) :1324-1334
[7]   Skewed maturation of memory HIV-specific CD8 T lymphocytes [J].
Champagne, P ;
Ogg, GS ;
King, AS ;
Knabenhans, C ;
Ellefsen, K ;
Nobile, M ;
Appay, V ;
Rizzardi, GP ;
Fleury, S ;
Lipp, M ;
Förster, R ;
Rowland-Jones, S ;
Sékaly, RP ;
McMichael, AJ ;
Pantaleo, G .
NATURE, 2001, 410 (6824) :106-111
[8]   Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing [J].
Cho, Alice ;
Gaebler, Christian ;
Olveira, Thiago ;
Ramos, Victor ;
Saad, Marwa ;
Lorenzi, Julio C. C. ;
Gazumyan, Anna ;
Moir, Susan ;
Caskey, Marina ;
Chun, Tae-Wook ;
Nussenzweig, Michel C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (04)
[9]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[10]   The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function [J].
Clutton, G. ;
Xu, Y. ;
Baldoni, P. L. ;
Mollan, K. R. ;
Kirchherr, J. ;
Newhard, W. ;
Cox, Kara ;
Kuruc, J. D. ;
Kashuba, A. ;
Barnard, R. ;
Archin, N. ;
Gay, C. L. ;
Hudgens, M. G. ;
Margolis, D. M. ;
Goonetilleke, N. .
SCIENTIFIC REPORTS, 2016, 6